Iterum Therapeutics plc ITRM on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
Business address:
3 DUBLIN LANDINGS, NORTH WALL QUAY, DUBLIN 1, Ireland, D01 H104
Phone: (872) 225-6077
3 DUBLIN LANDINGS, NORTH WALL QUAY, DUBLIN 1, Ireland, D01 H104
Phone: (872) 225-6077
Mailing address:
3 DUBLIN LANDINGS, NORTH WALL QUAY, DUBLIN 1, Ireland, D01 H104
3 DUBLIN LANDINGS, NORTH WALL QUAY, DUBLIN 1, Ireland, D01 H104
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Former names:
- Iterum Therapeutics Ltd - filings through 2018-05-01
Filings:
475 EDGAR filings since December 2, 2015
475 EDGAR filings since December 2, 2015
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- March 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- February 19, 2025 - EFFECT: Notice of Effectiveness Open documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - CORRESP: Correspondence Open documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
Selected Filings
[+] 8-K (current reports)
- March 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- February 14, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- February 7, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 7, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 14, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 13, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- August 14, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- August 2, 2024 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- April 26, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 18, 2025 - 3: Initial statement of beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- January 23, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- August 12, 2024 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G: Statement of acquisition of beneficial ownership by individuals Open documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 10 of 475 entries
Data source:
CIK0001659323.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
